205 related articles for article (PubMed ID: 18632609)
1. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2.
Kano S; Miyajima N; Fukuda S; Hatakeyama S
Cancer Res; 2008 Jul; 68(14):5572-80. PubMed ID: 18632609
[TBL] [Abstract][Full Text] [Related]
2. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
3. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Yin H; Li Z; Chen J; Hu X
J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
[TBL] [Abstract][Full Text] [Related]
5. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
[TBL] [Abstract][Full Text] [Related]
6. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
Wang J; Fang Y; Liu T
Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
[TBL] [Abstract][Full Text] [Related]
7. TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.
Yang X; Ma H; Zhang M; Wang R; Li X
Biochem Biophys Res Commun; 2023 Oct; 678():165-172. PubMed ID: 37640002
[TBL] [Abstract][Full Text] [Related]
8. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
[TBL] [Abstract][Full Text] [Related]
9. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).
Ryu YS; Lee Y; Lee KW; Hwang CY; Maeng JS; Kim JH; Seo YS; You KH; Song B; Kwon KS
J Biol Chem; 2011 Jul; 286(29):25729-38. PubMed ID: 21628460
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.
Liu J; Zhang C; Wang XL; Ly P; Belyi V; Xu-Monette ZY; Young KH; Hu W; Feng Z
Cell Death Differ; 2014 Nov; 21(11):1792-804. PubMed ID: 25146927
[TBL] [Abstract][Full Text] [Related]
11. TRIM32-TAX1BP1-dependent selective autophagic degradation of TRIF negatively regulates TLR3/4-mediated innate immune responses.
Yang Q; Liu TT; Lin H; Zhang M; Wei J; Luo WW; Hu YH; Zhong B; Hu MM; Shu HB
PLoS Pathog; 2017 Sep; 13(9):e1006600. PubMed ID: 28898289
[TBL] [Abstract][Full Text] [Related]
12. TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.
Borlepawar A; Rangrez AY; Bernt A; Christen L; Sossalla S; Frank D; Frey N
J Biol Chem; 2017 Jun; 292(24):10180-10196. PubMed ID: 28465353
[TBL] [Abstract][Full Text] [Related]
13. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma.
Cui X; Lin Z; Chen Y; Mao X; Ni W; Liu J; Zhou H; Shan X; Chen L; Lv J; Shen Z; Duan C; Hu B; Ni R
Mol Cell Biochem; 2016 Oct; 421(1-2):127-37. PubMed ID: 27573002
[TBL] [Abstract][Full Text] [Related]
14. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
Albor A; Kulesz-Martin M
Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
[TBL] [Abstract][Full Text] [Related]
15. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1.
Wei C; Wu J; Liu W; Lu J; Li H; Hai B
Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33728863
[TBL] [Abstract][Full Text] [Related]
17. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.
Sato T; Okumura F; Kano S; Kondo T; Ariga T; Hatakeyama S
J Cell Sci; 2011 Oct; 124(Pt 20):3492-502. PubMed ID: 21984809
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer.
Maeda H; Miyajima N; Kano S; Tsukiyama T; Okumura F; Fukuda S; Hatakeyama S
Mol Cancer Res; 2009 Sep; 7(9):1553-62. PubMed ID: 19723876
[TBL] [Abstract][Full Text] [Related]
19. TRIM32 is an E3 ubiquitin ligase for dysbindin.
Locke M; Tinsley CL; Benson MA; Blake DJ
Hum Mol Genet; 2009 Jul; 18(13):2344-58. PubMed ID: 19349376
[TBL] [Abstract][Full Text] [Related]
20. Tripartite containing motif 32 modulates proliferation of human neural precursor cells in HIV-1 neurodegeneration.
Fatima M; Kumari R; Schwamborn JC; Mahadevan A; Shankar SK; Raja R; Seth P
Cell Death Differ; 2016 May; 23(5):776-86. PubMed ID: 26586575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
